Ainos Inc
Follow $AIMD
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $AIMD by emailVeridion Score
BETALOW CONF · 4 of 6 factors measuredsnapshot unavailable for AIMD. Cause unavailable.
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is AIMD moving today?
Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
AIMD overview
Related filings and maps
Congress activity in AIMD
No receipt-qualified filings found.
AIMD contract awards, year to date.
Public federal awards linked to this ticker.
AIMD lobbying filings, year to date.
Registered lobbying filings matched to Ainos Inc.